NCT03276975View on ClinicalTrials.gov

A Randomized Trial of CT Fluoroscopy-guided Targeted Autologous Blood and Fibrin Glue Patching for Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 18, 2017

Primary Completion Date

March 19, 2020

Study Completion Date

March 19, 2020

Conditions
Cerebrospinal Fluid Leaks
Interventions
DRUG

TISSEEL

TISSEEL is a fibrin sealant indicated for use as an adjunct to hemostasis in adult and pediatric patients (\>1 month of age) undergoing surgery when control of bleeding by conventional surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical. TISSEEL is effective in heparinized patients

Trial Locations (1)

27710

Duke University, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER